[Federal Register Volume 63, Number 175 (Thursday, September 10, 1998)] [Notices] [Page 48523] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-24295] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated January 21, 1998, and published in the Federal Register on February 12, 1998, (63 FR 7182), Orpharm, Inc., 728 West 19th Street, Houston, Texas 77008, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methadone (9250)........................... II Methadone-intermediate (9254).............. II levo-alphacetylmethadol (9648)............. II ------------------------------------------------------------------------ The firm plans to manufacture methadone and methadone-intermediate for production of LAAM. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Orpharm, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. Therefore, pursuant to 21 U.S.C. 823 and 28 C.F.R. 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted. Dated: August 21, 1998. John H. King, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 98-24295 Filed 9-9-98; 8:45 am] BILLING CODE 4410-09-M